Timing and Triggers for Investigational Product Returns in Clinical Trials
Timing and Triggers for Investigational Product Returns in Clinical Trials When and Why to Return Investigational Products in Clinical Trials Returning unused or partially used Investigational Products (IPs) from trial sites is a key component of pharmaceutical logistics and regulatory compliance. Properly timed returns help prevent wastage, mitigate compliance risks, and ensure accurate reconciliation at…
Read More “Timing and Triggers for Investigational Product Returns in Clinical Trials” »